| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 2.775.403.039 $ | +435.857.900 $ | +33,4 % | 11 | 2.235.048.815 $ | +1.076.685.586 $ | +172,2 % | 9 | 997.324.011 $ | +388.239.112 $ | +156,3 % | 5 | ||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 655.974.329 $ | +67.677.415 $ | +11,5 % | 1 | 588.296.914 $ | +505.375.552 $ | +609,5 % | 1 | ||||
| Celcuity Inc. | CELC | → 0 | Schwach | 372.814.382 $ | +43.517.599 $ | +13,2 % | 1 | 329.296.783 $ | +174.530.832 $ | +112,8 % | 1 | 154.765.951 $ | +132.962.624 $ | +609,8 % | 1 |
| Ascendis Pharma A/S | ASND | → 0 | 350.281.925 $ | +119.679.711 $ | +51,9 % | 1 | 230.602.214 $ | +14.197.330 $ | +6,6 % | 1 | 216.404.884 $ | +50.038.160 $ | +30,1 % | 1 | |
| RHYTHM PHARMACEUTICALS, INC. | RYTM | → 0 | Neutral | 206.448.951 $ | -66.116.742 $ | -24,3 % | 1 | 272.565.693 $ | -15.824.885 $ | -5,5 % | 1 | 288.390.578 $ | +135.578.264 $ | +88,7 % | 1 |
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 229.507.270 $ | +56.222.766 $ | +32,4 % | 1 | 173.284.504 $ | +61.799.689 $ | +55,4 % | 1 | ||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 208.883.627 $ | +135.913.601 $ | +186,3 % | 1 | |||||||||
| Arcellx, Inc. | ACLX | → 0 | 202.651.781 $ | +39.475.481 $ | +24,2 % | 1 | |||||||||
| Spyre Therapeutics, Inc. | SYRE | → 0 | Neutral | 190.825.869 $ | +90.278.058 $ | +89,8 % | 1 | ||||||||
| Apogee Therapeutics, Inc. | APGE | → 0 | Schwach | 129.654.121 $ | -46.263.416 $ | -26,3 % | 1 | 175.917.537 $ | +122.203.014 $ | +227,5 % | 1 | ||||
| Nuvalent, Inc. | NUVL | → 0 | 161.922.737 $ | -5.570.175 $ | -3,3 % | 1 | 167.492.912 $ | +32.382.095 $ | +24,0 % | 1 | 135.110.817 $ | +30.184.583 $ | +28,8 % | 1 | |
| Travere Therapeutics, Inc. | TVTX | → 0 | Schwach | 163.469.258 $ | +72.777.959 $ | +80,2 % | 1 | ||||||||
| Edgewise Therapeutics, Inc. | EWTX | → 0 | Stark | 139.355.181 $ | +28.730.556 $ | +26,0 % | 1 | ||||||||
| FINANCIAL COUNSELORS INC | → 0 | 134.123.000 $ | +109.244.000 $ | +439,1 % | 1 | ||||||||||
| Protagonist Therapeutics, Inc | PTGX | → 0 | Neutral | 129.734.647 $ | +11.788.527 $ | +10,0 % | 1 | ||||||||
| 2.775.403.039 $ | +435.857.900 $ | +33,4 % | 11 | 2.235.048.815 $ | +1.076.685.586 $ | +172,2 % | 9 | 997.324.011 $ | +388.239.112 $ | +156,3 % | 5 | ||||